期刊
AMERICAN JOURNAL ON ADDICTIONS
卷 16, 期 2, 页码 71-78出版社
WILEY
DOI: 10.1080/10550490601184142
关键词
-
资金
- NATIONAL INSTITUTE ON DRUG ABUSE [F32DA005369, R01DA003906, R01DA012513, R37DA003906] Funding Source: NIH RePORTER
- NIDA NIH HHS [DA03906, DA05369, DA12513] Funding Source: Medline
The development of pharmacotherapies for cocaine addiction has been disappointingly slow. However, new neurobiological knowledge of how the brain is changed by chronic pharmacological insult with cocaine is revealing novel targets for drug development. Certain drugs currently being tested in clinical trials tap into the underlying cocaine-induced neuroplasticity, including drugs promoting GABA or inhibiting glutamate transmission. Armed with rationales derived from a neurobiological perspective that cocaine addiction is a pharmacologically induced disease of neuroplasticity in brain circuits mediating normal reward learning, one can expect novel pharmacotherapies to emerge that directly target the biological pathology of addiction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据